Trials / Completed
CompletedNCT00596817
Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes
A Double-blind, Randomised, Placebo-controlled, Multicentre, Relapse-prevention Study With Two Doses of [Vortioxetine] Lu AA21004 in Patients With Major Depressive Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 639 (actual)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the efficacy of Vortioxetine in the prevention of relapse of major depressive episodes in patients who responded to open-label treatment with Vortioxetine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | capsules, daily, orally |
| DRUG | Vortioxetine (Lu AA21004) | encapsulated tablets, daily, orally |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2009-09-01
- Completion
- 2009-10-01
- First posted
- 2008-01-17
- Last updated
- 2014-03-31
- Results posted
- 2014-03-31
Source: ClinicalTrials.gov record NCT00596817. Inclusion in this directory is not an endorsement.